Compliance & Medical Disclaimer
This article is for informational and educational purposes only and does not constitute medical, legal, regulatory, or professional advice. The compounds discussed are research chemicals not approved for human consumption by the US FDA, European Medicines Agency (EMA), UK MHRA, Australian TGA, Health Canada, or any other major regulatory authority. They are sold strictly for laboratory research use. WolveStack does not employ medical staff, does not diagnose, treat, or prescribe, and makes no health claims under FTC, UK ASA, EU MDR/UCPD, or AU TGA standards. Always consult a licensed healthcare professional in your jurisdiction before considering any peptide protocol. This site contains affiliate links (FTC 2023 endorsement guidelines compliant); we may earn a commission on qualifying purchases at no additional cost to you. Some compounds discussed are on the WADA prohibited list — competitive athletes should verify current status with their governing body before any research use. Use of research chemicals may be illegal in your jurisdiction.
Editorial policy
Editorial review process: WolveStack Research Team — collective expertise in peptide pharmacology, regulatory science, and research literature analysis. We synthesize peer-reviewed studies, regulatory filings, and clinical trial data; we do not provide medical advice or treatment recommendations. Content is reviewed and updated as new evidence emerges.
Medical Disclaimer
This article is for informational and educational purposes only and does not constitute medical advice. The compounds discussed are research chemicals that are not FDA-approved for human use. Always consult a licensed healthcare professional before considering any peptide protocol. WolveStack has no medical staff and does not diagnose, treat, or prescribe. See our full disclaimer.
AOD-9604 is administered via subcutaneous injection using 29-31 gauge insulin syringes. Inject into abdominal pinch-fold at 45-degree angle, 250-500 mcg once daily in a fasted state (6+ hours post-meal). Rotate injection sites to prevent lipodystrophy. Maintain strict sterile technique. Peak effect occurs 15-20 minutes post-injection; the peptide clears by 90 minutes.
Why Subcutaneous: Route of Administration Rationale
AOD-9604 is administered exclusively via subcutaneous (subQ) injection, not intramuscular (IM) or intravenous. This route is optimal for peptides of this size (15 amino acids).
Subcutaneous advantages: SubQ injection deposits the peptide in the subcutaneous tissue layer (between skin and muscle), where it's absorbed into surrounding blood vessels at a controlled rate. This route provides reliable, predictable absorption kinetics. SubQ injection is less painful than IM (smaller gauge needles work well), and the injection site is accessible for self-administration. For peptides like AOD-9604 with short half-lives, subQ absorption is fast enough (peak concentration in 5-10 minutes) while maintaining bioavailability.
Intramuscular: not recommended for AOD-9604. IM injection would be unnecessary—peptides absorb adequately from subQ tissue, and IM injection carries higher risks (nerve/blood vessel injury, higher pain, more tissue trauma). IM is reserved for larger molecular weight compounds or slow-release formulations.
Intravenous: not practical. IV administration would provide immediate peak concentration but requires sterile medical conditions and offers no practical advantage over subQ for a short-half-life peptide like AOD-9604.
SubQ injection also mimics physiologic peptide administration—many endogenous peptides are delivered via subQ routes clinically (insulin, GLP-1 agonists, growth hormone secretagogues).
Site Selection: Abdominal Injection and Rotation Protocol
The abdominal area is the standard injection site for AOD-9604 due to its accessibility, ease of self-injection, and excellent absorption kinetics.
Preferred sites: Lower abdomen (2-3 inches lateral of navel, 2-3 inches below navel). This area has ample subcutaneous tissue, is painless to inject, and allows easy visualization and rotation. Avoid injecting directly on or within 1 inch of the navel (risk of hitting underlying structures).
Alternative sites: Abdominal flanks (sides, beneath ribs), upper thighs (anterior and lateral), upper arms (triceps area). These are secondary sites useful for rotation and preventing lipodystrophy. Avoid areas with visible veins or tendons.
Rotation protocol: Consistent use of the same injection site can cause lipodystrophy (localized fat loss or thickening from repeated trauma and inflammation). To prevent this, rotate sites systematically. Example 7-day rotation: Monday (abdomen left), Tuesday (abdomen right), Wednesday (left flank), Thursday (right flank), Friday (left thigh), Saturday (right thigh), Sunday (left arm). Repeat. This distributes injection trauma and allows tissue recovery.
Site spacing: Inject at least 1 inch away from previous injection sites. This allows each site 1-2 weeks recovery between injections, minimizing lipodystrophy risk.
Step-by-Step Injection Technique
Proper injection technique ensures sterile administration, consistent absorption, and pain minimization.
Preparation (before injection): (1) Wash hands thoroughly with soap and water. (2) Gather supplies: prepared syringe with AOD-9604, alcohol pad, unused sterile needle (29-31 gauge 1/2 inch), trash container. (3) Inspect the vial rubber stopper for tears or contamination. (4) Wipe the rubber stopper with an alcohol pad in circular motions (10 seconds) and allow to dry (don't touch the sterilized area with fingers).
Drawing the dose: (1) Attach a fresh sterile needle to the syringe if not already attached. (2) Draw back the plunger to the desired dose volume (e.g., 0.25 mL for 250 mcg if concentration is 1000 mcg/mL). (3) Insert the needle through the sterilized rubber stopper at a 45-degree angle. (4) Inject the drawn air into the vial (prevents creating a vacuum). (5) Invert the vial, keeping the needle tip submerged in the liquid. (6) Slowly withdraw the plunger to draw the desired dose. (7) Keep the needle tip submerged until the syringe is full. (8) Withdraw the needle from the vial. (9) Replace the drawing needle with a fresh, sterile injection needle (29-31 gauge, 1/2 inch). This prevents dulling the needle (drawing through rubber dulls the tip) and ensures the injection needle is sterile.
Site preparation: (1) Locate the injection site (abdominal area, following rotation protocol). (2) Clean the area with an alcohol pad using circular motions (10 seconds) and allow to dry (2-3 seconds). (3) Do not re-touch the sterilized area with fingers.
Injection: (1) With your non-dominant hand, gently pinch 1-2 inches of skin to create a subcutaneous fold. The fold should be firm but comfortable (not excessively tight). (2) With your dominant hand, position the needle at a 45-degree angle to the pinched skin. (3) In one smooth motion, insert the needle through the skin into the subcutaneous tissue. The needle should be visible beneath the skin but not penetrating to muscle. (4) Once inserted, release the pinched skin with your non-dominant hand (if needed) to allow comfort. (5) Slowly depress the syringe plunger over 2-3 seconds, injecting the AOD-9604 into the tissue. Slow injection minimizes discomfort. (6) Once the plunger is fully depressed, wait 2-3 seconds to allow the peptide to diffuse into tissue. (7) Smoothly withdraw the needle at the same angle of insertion (45 degrees). (8) Do not massage the injection site (massage can alter absorption kinetics and cause bruising). (9) Apply gentle pressure with a clean tissue if bleeding occurs (rare, but possible with larger vessels hit). (10) Dispose of the used needle and syringe in an appropriate sharps container (not regular trash).
Needle Gauge and Syringe Specifications
Needle selection affects pain, tissue trauma, and injection consistency. AOD-9604 is best administered with small-gauge needles.
Recommended: 29-31 gauge, 1/2 inch. This needle size is thin (minimal pain), short enough for subQ injection (subcutaneous tissue is 1/4 to 1/2 inch deep), and prevents accidental IM injection. Common sources include standard insulin syringes (U-100: 0.3 mL, 0.5 mL, 1 mL). A 1 mL syringe is most versatile if AOD-9604 concentration varies (250-1000 mcg/mL).
Avoid: Large gauge (22-25 gauge) causes unnecessary pain and tissue trauma. Very small gauge (32+) can cause clogging with viscous peptide solutions and requires excessive force to push. Longer needles (5/8"+) risk IM injection if inserted fully—subQ tissue is only 1/2" deep.
Syringe type: Standard tuberculin or insulin syringes (typically 0.5-1 mL) are ideal. These syringes have markings for precise dosing and fit 29-31 gauge needles. Mark your syringe with tape or marker at your target volume (e.g., if 250 mcg = 0.25 mL, mark the syringe at the 0.25 mL line) to ensure consistent dosing.
Fasting State Requirement: Why 6+ Hours Post-Meal Matters
AOD-9604 efficacy depends critically on fasted state (6+ hours post-meal, ideally post-overnight fast, typically upon waking). This is not optional; it's mechanistically essential.
Why fasting matters: In the fasted state, insulin is low (<10 mIU/mL), cortisol and epinephrine are elevated (naturally higher in the morning), and adipose tissue is maximally sensitive to lipolytic signaling. Insulin suppresses HSL (hormone-sensitive lipase), the enzyme AOD-9604 activates. High insulin directly blocks the lipolytic signal. Empirical evidence: injecting AOD-9604 in a fasted state delivers 2-3x greater fat loss than fed injection.
Timing: Inject upon waking (6-8 hours post-dinner). Refrain from eating for 20-30 minutes post-injection to allow AOD-9604 to work unimpeded by insulin. After 30 minutes post-injection, consume breakfast if desired (AOD-9604 has already triggered lipolysis and is beginning to clear).
Exception: If you forget your fasted injection, don't inject after eating. Instead, wait until the next morning's fasted state to resume dosing. One missed dose is fine; one non-fasted dose is suboptimal.
Sterile Technique and Contamination Prevention
Peptides are vulnerable to contamination. A single contaminated injection can cause abscess, systemic infection, or localized cellulitis. Strict sterile technique is non-negotiable.
Critical rules: (1) Never reuse needles. Each injection requires a fresh, sterile needle for drawing and injecting. (2) Never reuse syringes unless you're certain they're sterile (not recommended for home use). (3) Never touch the needle tip, rubber stopper, or injection site after sterilization with alcohol. (4) Never share vials or syringes with other people (cross-contamination risk). (5) Keep vials tightly capped when not in use. (6) Discard the vial if the rubber stopper appears damaged, torn, or discolored. (7) Wipe the rubber stopper with a fresh alcohol pad before each injection.
Storage: Keep vials at room temperature (68-77°F) in a dark place, away from direct sunlight, or refrigerated (36-46°F) if preferred. Once reconstituted (if using lyophilized powder), use within 30 days if stored at room temperature, 60 days if refrigerated. Lyophilized (powder) vials can be stored at room temperature or refrigerated indefinitely if unopened.
Travel and Storage Considerations
AOD-9604 users frequently travel and require practical guidance on maintaining protocol during trips. Understanding storage requirements and travel logistics prevents waste and ensures efficacy.
Room temperature storage: Lyophilized (powder) AOD-9604 is stable at room temperature (68-77°F) when kept in a dark place away from direct sunlight. Vials remain stable indefinitely unopened. Once reconstituted (mixed with bacteriostatic water), the solution is stable for 30 days at room temperature. For short trips (under 5 days), room temperature storage is convenient and safe.
Cold chain during travel: For longer trips or if traveling to hot climates (where room temperature exceeds 77°F), refrigeration (36-46°F) is preferable. Reconstituted AOD-9604 is stable for 60 days refrigerated (double the room temperature stability). If traveling by air, use an insulated travel case with ice packs or purchase small doses of pre-reconstituted AOD-9604 at your destination if possible.
TSA and customs considerations: Lyophilized AOD-9604 powder in vials resembles pharmaceutical pills to TSA screening. It is legal to travel with AOD-9604 within the United States (as a research chemical). However, international travel requires caution. Some countries have strict regulations on peptide imports. To avoid confusion: carry your AOD-9604 in carry-on (not checked baggage—cold packs in checked luggage may leak). If questioned, explain it's a research chemical for personal research purposes. Avoid declaring it as a medication. When crossing international borders, verify the destination country's regulations in advance; some countries restrict peptide imports, which could result in confiscation or legal issues.
Injection while traveling: If traveling to another time zone, maintain your fasted morning injection. For example, if flying from US East Coast to Europe (6-hour time difference), inject at your usual local morning time at your destination (not at your home time). This maintains the fasted protocol advantage. Using an alarm or phone reminder helps maintain consistency. If you're flying overnight and sleep through your usual injection time, inject upon waking in the new time zone—one missed dose is not critical.
Backup supply management: Experienced travelers keep a small backup supply (2-3 vials) at home and travel with 1-2 vials. This prevents inconvenience if you're delayed and can't return home on schedule. Don't travel with your entire cycle's supply—if luggage is lost or delayed, you've lost weeks of protocol. Keep supplies distributed.
Protocol continuity: Skipping doses during travel is acceptable if necessary. If you miss 2-3 injections during a week-long trip, resume your protocol upon returning home. The short half-life of AOD-9604 means there's no long-term detriment from brief interruptions. However, maintain consistency when possible to maximize fat loss results.
Trusted Research-Grade Sources
Below are the two vendors we recommend for research peptides — both publish independent third-party Certificates of Analysis (COAs) and ship internationally. Affiliate links: we earn a small commission at no extra cost to you (see Affiliate Disclosure).
Particle Peptides
Independently HPLC-tested, transparent COAs, comprehensive product range.
Browse Particle Peptides →Limitless Life Nootropics
Premium research peptides with strong customer support and verified purity.
Browse Limitless Life →